US2019133926A1PendingUtilityA1
Burn Pill Pharmaceutical Smoking Cylinder
Est. expiryNov 7, 2037(~11.3 yrs left)· nominal 20-yr term from priority
Inventors:Tremaine Jackson
A61K 9/2068A61K 9/2077A61K 9/2009A61M 11/041A61K 9/007A24B 15/303A24F 1/28A61K 9/2013A61M 15/06A24B 15/167
19
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A medicated pill having a composition comprising of the active pharmaceutical agent (API) in a concentration in the range of 5% to 40% by weight and excipients in a concentration in the range of 20% to 80% by weight, based on the total weight of the pharmaceutical composition.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A medicated pill having a composition comprising of the active pharmaceutical agent (API) in a concentration in the range of 5% to 40% by weight and excipients in a concentration in the range of 20% to 80% by weight, based on the total weight of the pharmaceutical composition.
2 . The medicated pill having a composition of claim 1 , wherein the particle diameter of the ingredients of the composition is in the range of 0.01 mm to 0.1 mm.
3 . The medicated pill having a composition of claim 1 , wherein the active pharmaceutical agent is selected from the group consisting of antibiotics, antipyretics, vitamins and herbs.
4 . The medicated pill having a composition of claim 3 , wherein the antibiotics is selected from the group consisting of β-lactams, tetracyclines, macrolides, aminoglycosides, anti-metabolites, nucleic acid analogs, antifungals and antivirals.
5 . The medicated pill having a composition of claim 3 , wherein the antipyretics is chosen from the group consisting of non-steroidal anti-inflammatory drugs.
6 . The medicated pill having a composition of claim 1 , wherein the excipient selected is organic.
7 . The medicated pill having a composition of claim 1 , wherein the excipient selected is inorganic.
8 . The medicated pill having a composition of claim 6 , wherein the organic excipient is selected from the group consisting of cellulose and its derivatives, starch and its derivatives, waxes and herbs.
9 . The medicated pill having a composition of claim 7 , wherein the inorganic excipient is selected from the group comprising of calcium and sodium salts.
10 . The medicated pill having a composition of claim 7 , wherein the inorganic excipient is magnesium stearate.
11 . The medicated pill having a composition of claim 7 , wherein the inorganic excipient is talc.
12 . The medicated pill having a composition of claim 7 , wherein the inorganic excipient is titanium dioxide.
13 . The medicated pill of claim 1 , wherein the shape of the pill is cylindrical having a diameter ranging between 3 mm and 8 mm and the length ranging between 5 and 15 mm.
14 . The medicated pill of claim 1 , wherein the pill is disc shaped having a diameter ranging between 8 and 15 mm and the thickness ranging between 3 and 10 mm.
15 . The smoking cylinder for inhaling the vapours of the said medicated pill, having a length ranging between 50 and 250 mm and an inner diameter ranging from 5 and 20 mm.
16 . The smoking cylinder of claim 15 , wherein an orifice is provided internally in the said smoking cylinder.
17 . The smoking cylinder of claim 15 , wherein, the end of smoking cylinder is provided with cotton.
18 . The smoking cylinder of claim 17 , wherein the said cotton end of the said cylinder is blended with a mixture of inorganic salts and polymers.
19 . The smoking cylinder of claim 15 , wherein the material used for the said cylinder is metal.
20 . The smoking cylinder of claim 15 , wherein the material used for the said cylinder is glass.
21 . The smoking cylinder of claim 15 , wherein the material used for the said cylinder is paper made of hemp.Join the waitlist — get patent alerts
Track US2019133926A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.